IDEAS home Printed from https://ideas.repec.org/a/kap/pubcho/v193y2022i3d10.1007_s11127-022-01005-0.html
   My bibliography  Save this article

Capture and passive predation in times of COVID-19 pandemic

Author

Listed:
  • Samira Guennif

    (Université Sorbonne Paris Nord)

Abstract

In the midst of a health crisis, a drug in development and candidate for COVID-19 contagious disease was granted orphan-drug designation (ODD). This decision by the US Food and Drug Administration was immediately denounced as an abuse of the Orphan Drug Act (ODA). This paper outlines how this decision may be considered as the result of a complex case of capture along the regulatory process. Therefore, a case study of the remdesivir episode is conducted, combining the definition of a framework for the analysis of capture and the identification of stylized facts marking the trajectory of a repositioned drug and candidate for COVID-19. In doing so, arguments are put forward to show to what extent this granting of ODD can be described as the result of a series of captures, a case of weak capture however that calls for an amendment of the ODA to preclude drugs for contagious and communicable epidemic diseases from obtaining orphan status in the first place.

Suggested Citation

  • Samira Guennif, 2022. "Capture and passive predation in times of COVID-19 pandemic," Public Choice, Springer, vol. 193(3), pages 163-186, December.
    • Handle: RePEc:kap:pubcho:v:193:y:2022:i:3:d:10.1007_s11127-022-01005-0
    DOI: 10.1007/s11127-022-01005-0
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s11127-022-01005-0
    File Function: Abstract
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s11127-022-01005-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. DiMasi, Joseph A. & Grabowski, Henry G. & Hansen, Ronald W., 2016. "Innovation in the pharmaceutical industry: New estimates of R&D costs," Journal of Health Economics, Elsevier, vol. 47(C), pages 20-33.
    2. Mehrdad Vahabi, 2020. "Introduction: a symposium on the predatory state," Public Choice, Springer, vol. 182(3), pages 233-242, March.
    3. North,Douglass C., 1991. "Institutions, Institutional Change and Economic Performance," Cambridge Books, Cambridge University Press, number 9780521394161, October.
    4. Mehrdad Vahabi, 2016. "A positive theory of the predatory state," Public Choice, Springer, vol. 168(3), pages 153-175, September.
    5. Robert Tollison, 2012. "The economic theory of rent seeking," Public Choice, Springer, vol. 152(1), pages 73-82, July.
    6. Sara Reardon, 2014. "Regulators adopt more orphan drugs," Nature, Nature, vol. 508(7494), pages 16-17, April.
    7. Kolyazina L. V., 2011. "State as the subject of economy regulation," Вестник Саратовского государственного социально-экономического университета, CyberLeninka;Государственное образовательное учреждение высшего профессионального образования "Саратовский государственный социально-экономического университет", issue 3, pages 22-24.
    8. Mueller,Dennis C., 2003. "Public Choice III," Cambridge Books, Cambridge University Press, number 9780521894753, October.
    9. Brezis, Elise S. & Cariolle, Joël, 2019. "The revolving door, state connections, and inequality of influence in the financial sector," Journal of Institutional Economics, Cambridge University Press, vol. 15(4), pages 595-614, August.
    10. Richard A. Posner, 1974. "Theories of Economic Regulation," Bell Journal of Economics, The RAND Corporation, vol. 5(2), pages 335-358, Autumn.
    11. Samira Guennif & Shadlen Ken & Guzman Alenka & N. Lalitha, 2011. "Intellectual property, pharmaceuticals and public health: access to drugs in developing countries," Post-Print hal-01345877, HAL.
    12. J.A. den Hertog, 2010. "Review of economic theories of regulation," Working Papers 10-18, Utrecht School of Economics.
    13. Todd Gammie & Christine Y Lu & Zaheer Ud-Din Babar, 2015. "Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries," PLOS ONE, Public Library of Science, vol. 10(10), pages 1-24, October.
    14. Peter T. Leeson & M. Scott King & Tate J. Fegley, 2020. "Regulating quack medicine," Public Choice, Springer, vol. 182(3), pages 273-286, March.
    15. Jean-Jacques Laffont & Jean Tirole, 1993. "A Theory of Incentives in Procurement and Regulation," MIT Press Books, The MIT Press, edition 1, volume 1, number 0262121743, April.
    16. Sam Peltzman, 1989. "The Economic Theory of Regulation after a Decade of Deregulation," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 20(1989 Micr), pages 1-59.
    17. Braithwaite,John & Drahos,Peter, 2000. "Global Business Regulation," Cambridge Books, Cambridge University Press, number 9780521784993, October.
    18. Mitnick, Barry M., 1981. "The strategic uses of regulation -- And deregulation," Business Horizons, Elsevier, vol. 24(2), pages 71-83.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mountain, Bruce R., 2019. "Ownership, regulation, and financial disparity: The case of electricity distribution in Australia," Utilities Policy, Elsevier, vol. 60(C), pages 1-1.
    2. Sanjay Patnaik, 2019. "A cross-country study of collective political strategy: Greenhouse gas regulations in the European Union," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 50(7), pages 1130-1155, September.
    3. J.A. den Hertog, 2010. "Review of economic theories of regulation," Working Papers 10-18, Utrecht School of Economics.
    4. Haselmann, Rainer & Sarkar, Arkodipta & Singla, Shikhar & Vig, Vikrant, 2022. "The political economy of financial regulation," LawFin Working Paper Series 45, Goethe University, Center for Advanced Studies on the Foundations of Law and Finance (LawFin).
    5. Bálint Madlovics & Bálint Magyar, 2021. "Post-communist predation: modeling reiderstvo practices in contemporary predatory states," Public Choice, Springer, vol. 187(3), pages 247-273, June.
    6. Magnus Söderberg, 2008. "Uncertainty and regulatory outcome in the Swedish electricity distribution sector," European Journal of Law and Economics, Springer, vol. 25(1), pages 79-94, February.
    7. Lehr, William & Sicker, Douglas, 2017. "Communications Act 2021," 28th European Regional ITS Conference, Passau 2017 169478, International Telecommunications Society (ITS).
    8. Phares, Jonathan & Dobrzykowski, David D. & Prohofsky, Jodi, 2021. "How policy is shaping the macro healthcare delivery supply chain: The emergence of a new tier of retail medical clinics," Business Horizons, Elsevier, vol. 64(3), pages 333-345.
    9. Paul Joskow & Roger Noll, 2013. "Alfred E. Kahn, 1917–2010," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 42(2), pages 107-126, March.
    10. Jaccard, Mark, 1995. "Oscillating currents : The changing rationale for government intervention in the electricity industry," Energy Policy, Elsevier, vol. 23(7), pages 579-592, July.
    11. Elvio Accinelli & Osvaldo Salas, 2019. "El estado de bienestar como un bien público no excluible / The welfare state as a public good not excludable," Estudios Económicos, El Colegio de México, Centro de Estudios Económicos, vol. 34(2), pages 243-273.
    12. Richard Higgins & Arijit Mukherjee, 2010. "Deregulation redux: does mandating access to bottleneck facilities necessarily improve welfare?," Public Choice, Springer, vol. 142(3), pages 363-377, March.
    13. Daniel J. Smith & Macy Scheck, 2023. "Examining the public interest rationale for regulating whiskey with the pure food and drugs act," Public Choice, Springer, vol. 196(1), pages 85-122, July.
    14. Matthias Benz & Bruno S. Frey, "undated". "Corporate Governance: What can we Learn from Public Governance?," IEW - Working Papers 166, Institute for Empirical Research in Economics - University of Zurich.
    15. Bruno Deffains & Dominique Demougin, 2023. "Capitation taxes and the regulation of professional services," European Journal of Law and Economics, Springer, vol. 55(2), pages 167-193, April.
    16. Agrell, Per J. & Bogetoft, Peter & Mikkers, Misja, 2013. "Smart-grid investments, regulation and organization," Energy Policy, Elsevier, vol. 52(C), pages 656-666.
    17. Johannes M. Bauer, 2005. "Regulation and state ownership: conflicts and complementarities in eu telecommunications," Annals of Public and Cooperative Economics, Wiley Blackwell, vol. 76(2), pages 151-177, June.
    18. Adwoa Asantewaa & Tooraj Jamasb & Manuel Llorca, 2022. "Electricity Sector Reform Performance in Sub-Saharan Africa: A Parametric Distance Function Approach," Energies, MDPI, vol. 15(6), pages 1-29, March.
    19. Matthew D. Mitchell, 2019. "Uncontestable favoritism," Public Choice, Springer, vol. 181(1), pages 167-190, October.
    20. Harold Mulherin, J., 2007. "Measuring the costs and benefits of regulation: Conceptual issues in securities markets," Journal of Corporate Finance, Elsevier, vol. 13(2-3), pages 421-437, June.

    More about this item

    Keywords

    Predation; Capture; Regulation; Rent-seeking; Orphan drug; COVID-19;
    All these keywords.

    JEL classification:

    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
    • K23 - Law and Economics - - Regulation and Business Law - - - Regulated Industries and Administrative Law
    • L12 - Industrial Organization - - Market Structure, Firm Strategy, and Market Performance - - - Monopoly; Monopolization Strategies
    • L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
    • P14 - Political Economy and Comparative Economic Systems - - Capitalist Economies - - - Property Rights

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:kap:pubcho:v:193:y:2022:i:3:d:10.1007_s11127-022-01005-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.